Source: ERJ Open Res, 7 (1) 00582-2020; 10.1183/23120541.00582-2020
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Edouard Guenzi, Johan Pluvy, Alice Guyard, Marina Nguenang, Khedidja Rebah, Zoubida Benrahmoune, Jérome Lamoril, Aurelie Cazes, Valérie Gounant, Solenn Brosseau, Catherine Boileau, Gérard Zalcman, Nathalie Théou-Anton. A new KIF5B–ERBB4 gene fusion in a lung adenocarcinoma patient. ERJ Open Res, 7 (1) 00582-2020; 10.1183/23120541.00582-2020

Member's Comments

No comment yet.

Related content which might interest you: Identification of a novel crizotinib-sensitive BCL11A-ALK gene fusion in a nonsmall cell lung cancer patient Source: Eur Respir J , 49 (4)  1602149; DOI: 10.1183/13993003.02149-2016 Year: 2017 FGFR1 gene aberrations and FGFR1 protein expression in squamous non-small cell lung cancer (Sq-NSCLC). Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 Is caveolin-1 lost as a tumor suppressor gene in lung carcinoma? Source: Annual Congress 2004 - Lung development and cancer Year: 2004 p53 gene mutations in lung cancer in Korean Source: Eur Respir J 2005; 26: Suppl. 49, 327s Year: 2005 The analysis of CHEK2 gene mutation in small cell lung cancer Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients Source: Eur Respir Rev 2014; 23: 390-392 Year: 2014 Combined expression of p53, Bcl-2 and p21WAF-1 proteins in endobronchial biopsies may be associated with lung cancer prognosis Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001 The prognostic value of altered pRb and p53 protein expression in non-small cell lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 363s Year: 2003 Tumoural tissue specific promoter hypermethylation of distinct tumour suppressor genes in a case with nonsmall cell lung carcinoma: a case report Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer Year: 2009 Polymorphism in GSTM1, GSTT1, p53 and CCR5 genes and lung cancer progression: relation to p53 and Ki-67 protein expression in tumors of non-small cell lung cancer patients Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006 c-erbB-1 and c-erbB-2 receptors genetic abnormalities and protein expression in lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 705s Year: 2004 The role of NPM, p14arf and MDM2 in precursors of bronchial squamous cell carcinoma Source: Eur Respir J 2008; 32: 678-686 Year: 2008 Nuclear expression of Y-Box binding protein (YB-1) as a negative prognostic marker in non-small cell lung cancer Source: Annual Congress 2003 - Lung cancer biology Year: 2003 Clinical relevance of p53 and K-ras gene mutations in bronchial margins in surgically treated nonsmall cell lung cancer (NSCLC) patients Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002 Mutant P53 expression in squamous cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 72s Year: 2002 K-RAS oncogenic mutations in patients with nonsmall cell lung cancer Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 p53 and mdm2 expression in nonsmall cell lung cancer (NSCLC): the lack of prognostic relevance Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001 HER-2/neu oncoprotein expression in nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002 Arg72Pro P53 gene polymorphism is associated with P53 mutations in non-small cell lung cancer (NSCLC) patients Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004 The role of P53 tumor suppressor gene mutations in early diagnosis of lung cancer among patients with solitary pulmonary nodule Source: Annual Congress 2009 - Pathogenesis of lung cancer Year: 2009